MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
1996 |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
16.9 M |
Market Cap[1] |
$ 14.6 M |
EBITDA (LTM) |
$ -14 M |
P/E (LTM) |
-0.68 |
P/S (LTM) |
0.36 |
EPS (LTM) |
-1.29 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | USA |
 |
EDAP TMS S.A.
EDAP
|
- | - | $ 162 M | Nasdaq Global Market |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | USA |
 |
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | USA |
 |
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | USA |
 |
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | USA |
 |
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market |  China |
 |
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | USA |
 |
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | USA |
 |
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | USA |
 |
AxoGen
AXGN
|
$ 47.29 | 1.85 % | $ 2.18 B | Nasdaq Capital Market,SPB | USA |
 |
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | USA |
 |
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | USA |
 |
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | USA |
 |
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | USA |
 |
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | USA |
 |
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | USA |
 |
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | USA |
 |
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market |  Israel |
 |
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | USA |
 |
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market |  Canada |
 |
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
$ 17.24 | -0.06 % | $ 1.32 B | Nasdaq Global Select Market,SPB | USA |
 |
Inogen
INGN
|
$ 6.15 | 1.57 % | $ 164 M | Nasdaq Global Select Market,SPB | USA |
 |
Integer Holdings Corporation
ITGR
|
$ 125.05 | -0.18 % | $ 4.34 B | NYSE,SPB | USA |
 |
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | USA |
 |
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | USA |
 |
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | USA |
 |
LENSAR
LNSR
|
$ 6.17 | 2.14 % | $ 73.8 M | Nasdaq Capital Market | USA |
 |
Avanos Medical
AVNS
|
$ 24.99 | - | $ 1.16 B | NYSE,SPB | USA |
 |
MiMedx Group
MDXG
|
$ 4.22 | -2.76 % | $ 624 M | Nasdaq Global Select Market | USA |
 |
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | USA |
 |
ClearPoint Neuro
CLPT
|
$ 14.58 | 2.59 % | $ 413 M | Nasdaq Capital Market | USA |
 |
Cytosorbents Corporation
CTSO
|
$ 0.38 | 5.56 % | $ 23.6 M | Nasdaq Capital Market | USA |
 |
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market | USA |
 |
NuVasive
NUVA
|
- | - | $ 2.07 B | Nasdaq Global Select Market,SPB | USA |
 |
Natus Medical Incorporated
NTUS
|
- | 1.94 % | $ 1.05 B | Nasdaq Global Select Market,SPB | USA |
 |
Nevro Corp.
NVRO
|
- | - | $ 217 M | NYSE,SPB | USA |
 |
Butterfly Network
BFLY
|
$ 9.82 | 11.27 % | $ 2.43 B | NYSE | USA |
 |
Profound Medical Corp.
PROF
|
$ 7.16 | -3.37 % | $ 216 M | Nasdaq Global Select Market | Canada |
 |
Quanterix Corporation
QTRX
|
$ 2.44 | -39.46 % | $ 104 M | Nasdaq Global Select Market,SPB | USA |
 |
InspireMD
NSPR
|
$ 0.76 | 3.05 % | $ 48.9 M | NYSE American | Israel |
 |
AVITA Medical
RCEL
|
$ 8.01 | 3.03 % | $ 223 M | Nasdaq Global Select Market |  Australia |
 |
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | USA |
 |
FONAR Corporation
FONR
|
- | - | $ 140 M | Nasdaq Capital Market | USA |
 |
Inari Medical
NARI
|
- | - | $ 4.23 B | Nasdaq Global Select Market,SPB | USA |
 |
Medigus Ltd.
MDGS
|
- | 10.28 % | $ 55.5 M | Nasdaq Global Select Market | Israel |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.